During the period spanning 1909 to 1943, pathogenesis research coalesced around the idea that genetic variation and defined virulence mechanisms govern disease outcomes. A key shift emphasized spontaneous or random genetic changes as drivers of virulence and resistance, reframing pathogenesis as a genetic process rather than solely host- or environment-driven. Serological grouping of pathogen strains emerged as a powerful tool, enabling linkage of specific groups to disease sources and clinical trajectories, thereby guiding diagnosis, epidemiology, and early vaccine concepts. Mechanistic investigations identified virulence factors, including enzymes that liquefy clots and facilitate tissue invasion, establishing core pathways of pathogenicity and sparking later anti-virulence approaches. Finally, patterns of metastatic spread and the existence of neurotropic infection highlighted the importance of anatomical and host-pathway considerations in disease progression.